ClinicalTrials.Veeva

Menu

Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Active, not recruiting

Conditions

Chronic Liver Disease

Treatments

Behavioral: Mobile chat messaging
Behavioral: Screening, brief intervention and referral to treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT06587568
21222731

Details and patient eligibility

About

The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. Specific objectives include:

  1. To assess whether the eligibility criteria were too restrictive by estimating the eligibility rate
  2. To assess how many eligible CLD patients accepted the invitation to participate in the trial
  3. To assess the participant retention rate through 6 months after treatment initiation
  4. To assess the intervention acceptability in terms of participants' engagement with and rating of the chat messaging intervention.
  5. To assess the safety of the intervention
  6. To estimate the intervention effect on alcohol use outcomes and liver functions
  7. To synthesise data to inform the sample size calculation in the future definitive trial
  8. To explore the participants' perception and experiences in the chat-based intervention

Enrollment

106 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥18 years
  2. Diagnosed with chronic liver disease
  3. Alcohol Use Disorders Identification Test score ≥8
  4. Own a smartphone with a mobile instant messaging app installed
  5. Able to read and communicate in Chinese

Exclusion criteria

  1. Having a psychiatric or psychological disease or on psychotropic drugs
  2. Participating in other alcohol reduction or abstinence programmes
  3. Require emergency or in-patient treatment after consultation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

106 participants in 2 patient groups

Mobile chat messaging
Experimental group
Description:
Mobile chat messaging + Screening-based alcohol intervention
Treatment:
Behavioral: Screening, brief intervention and referral to treatment
Behavioral: Mobile chat messaging
Brief intervention
Active Comparator group
Description:
Screening-based alcohol intervention only
Treatment:
Behavioral: Screening, brief intervention and referral to treatment

Trial contacts and locations

1

Loading...

Central trial contact

Tzu Tsun Luk, PhD, RN; Vanessa Wong, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems